Your choice for protein kinases and protein kinase substrates

Many protein kinases are involved in major diseases like cancer, Alzheimer, Parkinson and inflammatory processes, and there is an increased demand for finding therapeutic solutions. Several cancer therapies that specifically target protein kinases are already on the market and protein kinases are among the top targets the pharmaceutical industry has chosen as drug targets. Hence, the needs for testing and modulating kinase activity has been increasing steadily over the last decade. The demand for high quality products to achieve these goals is growing concomitantly.

KinaseDetect provides the most complete CK2 product line and a selected number of other highly purified recombinant human protein kinase. Recently, phosphatases have been added to the product list. Additionally, protein kinase substrates and protein kinase assays as service are available. Read about the history of KinaseDetect.

NEWS

KinaseDetect sponsors the 6th International Conference on Protein Kinase CK2 "Protein Kinase CK2: a catalyst for biology, medicine and structural biology, in Cologne, Germany, September 7 - 10, 2010.

KinaseDetect sponsors the 6th International Conference on Inhibitors of Protein Kinases in Warsaw, Poland, June 27 - July 1, 2009.

Carna Biosciences and its distributor KinaseDetect exhibit at the SBS 15th Annual Conference & Exhibition in Lille, France, April 26-30, 2009

KinaseDetect presents a poster on "Resorufin: A Lead for a New Protein Kinase CK2 Inhibitor" at Screening Europe 2009 in Berlin, Germany, February 23-25, 2009.

KinaseDetect presents a poster on "Expression and Purification of PI3 kinase alpha and Development of a Luminometric PI3 Kinase Activity Assay" at Screening Europe 2008 in Stockholm, Sweden, February 19-20, 2008.

KinaseDetect is sponsor of the Picosymposium: New Aspects of Cellular Signaling, June 01, 2007, SDU, Odense, Denmark